Publications

Below you will find links to several abstracts that pertain to our research:

• Use of Magnesium in Traumatic Brain Injury, Published by The Journal of the American Society of Experimental NeuroTherapeutics

  Use of Magnesium in Traumatic Brain Injury

  Sen, Ananda P. and Gulati, Anil

• ET-11: APS International Conference on Endothelin, 5.15, 2009

  ET receptor Antagonists in the Treatment of Diabetic Ketoacidosis

  Gulati A, Lavhale M, Koenig K, Havalad S

• Pharmacology 83(1):45-58, 2009.

  Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.

  Gulati A, Bhalla S, Matwyshyn G, Zhang Z, Andurkar SV.

• Prostate 67(7):701-13, 2007.

  IRL-1620, a tumor selective vasodilator, augments the uptake and efficacy of chemotherapeutic agents in prostate tumor rats.

  Rajeshkumar NV, Matwyshyn G, Gulati A.

• Methods and Findings in Experimental and Clinical Pharmacology 29(4):257-63, 2007.

  Effect of combination of endothelin receptor antagonist (TAK-044) and aspirin in middle cerebral artery occlusion model of acute ischemic stroke in rats.

  Briyal S, Gulati A, Gupta YK.

• Experimental Biology and Medicine (Maywood, N.J.) 231(6):1152-6, 2006.

  Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells.

  Bhalla S, Ciaccio N, Wang ZJ, Gulati A.

• European Journal of Pharmacology 43(1-3):48-53, 2006.

  Endothelin ETA receptor blockade potentiates morphine analgesia but does not affect gastrointestinal transit in mice.

  Matwyshyn GA, Bhalla S, Gulati A.

• Experimental Biology and Medicine (Maywood, N.J.) 231(6):1120-2, 2006.

  Effect of the ET(B) receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats.

  Rai A, Rajeshkumar NV, Gulati A.

• Breast Cancer Research and Treatment 94(3):237-47, 2005.

  Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats.

  Rajeshkumar NV, Rai A, Gulati A.

• Life Sciences 77(1):15-27, 2005.

  Effect of endothelin antagonist (TAK-044) on cerebral ischemic volume, oxidative stress markers and neurobehavioral parameters in the middle cerebral artery occlusion model of stroke in rats.

  Gupta YK, Briyal S, Sharma U, Jagannathan NR, Gulati A.

• Brain Research 1064(1-2):126-35, 2005.

  Morphine tolerance does not develop in mice treated with endothelin-A receptor antagonists.

  Bhalla S, Matwyshyn G, Gulati A.

• Journal of Pharmacy and Pharmacology 57(7):869-76, 2005.

  ET(B) receptor agonist, IRL 1620, does not affect paclitaxel plasma pharmacokinetics in breast tumour bearing rats.

  Rai A, Rajeshkumar NV, Shord S, Gulati A.

• Pharmacology 72(1):20-5, 2004.

  Central endothelin-B receptor stimulation does not affect morphine analgesia in rats.

  Bhalla S, Matwyshyn G, Gulati A.

• Journal of Cardiovascular Pharmacology 44 (Suppl 1):S483-6, 2004

  Endothelin-1-induced vasodilatation in rat breast tumor is mediated through endothelin-B receptors.

  Gulati A, Rai A.

• Journal of Pharmacy and Pharmacology 56(2):271-5, 2004.

  Endothelin ETA receptor antagonist did not affect development of tolerance to glyceryl trinitrate in rat.

  Rai A, Bhalla S, Gulati A.

• Journal of Cardiovascular Pharmacology 44 (Suppl 1):S129-31, 2004.

  A novel combination of opiates and endothelin antagonists to manage pain without any tolerance development.

  Gulati A, Bhalla S, Matwyshyn G.

• Peptides 24(4):553-61, 2003.

  Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats.

  Bhalla S, Matwyshyn G, Gulati A.

• Cancer Chemotherapy and Pharmacology 51(1):21-8, 2003.

  Evidence for the involvement of ET(B) receptors in ET-1-induced changes in blood flow to the rat breast tumor.

  Rai A, Gulati A.

• Peptides 23(10):1837-45., 2002

  Potentiation of morphine analgesia by BQ123, an endothelin antagonist.

  Bhalla S, Matwyshyn G, Gulati A.